Equities

Transgene SA

Transgene SA

Actions
  • Price (EUR)0.85
  • Today's Change0.85 / --
  • Shares traded2.00
  • 1 Year change-42.57%
  • Beta--
Data delayed at least 20 minutes, as of Nov 14 2024 09:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments162750
Total Receivables, Net1.383.5911
Total Inventory------
Prepaid expenses0.861.661.38
Other current assets, total0.08140.07
Total current assets184762
Property, plant & equipment, net121111
Goodwill, net------
Intangibles, net0.080.080.09
Long term investments1.351.6721
Note receivable - long term----0
Other long term assets136.977.16
Total assets4566102
LIABILITIES
Accounts payable4.556.977.69
Accrued expenses3.60--0
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.331.191.40
Other current liabilities, total0.574.635.50
Total current liabilities101315
Total long term debt0.021.262.45
Total debt1.352.453.84
Deferred income tax------
Minority interest------
Other liabilities, total201518
Total liabilities302935
SHAREHOLDERS EQUITY
Common stock505049
Additional paid-in capital727270
Retained earnings (accumulated deficit)(106)(83)(51)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.64)(0.45)(1.42)
Total equity163867
Total liabilities & shareholders' equity4566102
Total common shares outstanding10110098
Treasury shares - common primary issue0.300.290
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.